CASI Pharmaceuticals Total Assets Growth & History (CASIF)
CASI Pharmaceuticals's total assets was $25.6M for fiscal 2025.
View full CASI Pharmaceuticals company overviewCASI Pharmaceuticals annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $25.6M | −$28.0M | −52.21% |
| 2024 | 2024-12-31 | $53.7M | −$21.6M | −28.69% |
| 2023 | 2023-12-31 | $75.3M | −$21.0M | −21.79% |
| 2022 | 2022-12-31 | $96.2M | −$42.1M | −30.42% |
| 2021 | 2021-12-31 | $138.3M | — | — |
CASI Pharmaceuticals quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $21.1M | −$10.1M | −32.49% |
| Q4 2025 | 2025-12-31 | $25.6M | −$28.0M | −52.21% |
| Q3 2025 | 2025-09-30 | $24.5M | — | — |
| Q2 2025 | 2025-06-30 | $31.2M | — | — |
| Q1 2025 | 2025-03-31 | $40.8M | — | — |
| Q4 2024 | 2024-12-31 | $53.7M | −$21.6M | −28.69% |
| Q4 2023 | 2023-12-31 | $75.3M | −$21.0M | −21.79% |
| Q4 2022 | 2022-12-31 | $96.2M | −$42.1M | −30.42% |
| Q4 2021 | 2021-12-31 | $138.3M | — | — |
CASI Pharmaceuticals total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, CASI Pharmaceuticals's total assets decreased from $138.3M to $25.6M, a change of −$112.6M. The latest reported quarter, Q2 2026, shows $21.1M.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CASI Pharmaceuticals source filings ↗